Filing Details

Accession Number:
0001193805-11-001067
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-06-07 17:27:37
Reporting Period:
2011-05-26
Filing Date:
2011-06-07
Accepted Time:
2011-06-07 17:27:37
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1034842 Rigel Pharmaceuticals Inc RIGL Pharmaceutical Preparations (2834) 943248524
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1009258 Deerfield Management Co /Ny 780 Third Avenue, 37Th Floor
New York NY 10017
No No Yes Yes
1010823 Deerfield Capital Lp 780 Third Avenue
37Th Floor
New York NY 10017
No No Yes Yes
1061970 Ltd International Deerfield C/O Citi Fund Services (Bvi) Ltd
Bison Court, Po Box 3460, Road Town
Tortola D8 --
No No Yes Yes
1301041 Deerfield Partners, Lp 780 Third Avenue
37Th Floor
New York NY 10017
No No Yes Yes
1352546 E James Flynn 780 Third Avenue
37Th Floor
New York NY 10017
No No Yes Yes
1354395 Deerfield Special Situations Fund, L.p. 780 3Rd Avenue
37Th Floor
New York NY 10017
No No Yes Yes
1354397 Ltd International Fund Situations Special Deerfield C/O Citi Hedge Fund Services (Bvi) Ltd
Bison Court, P.o. Box 3460
Road Town, Tortola D8 -
No No Yes Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-05-26 46,524 $8.00 470,425 No 4 P Indirect Through Deerfield Special Situations Fund, L.P.
Common Stock Acquisiton 2011-05-26 72,800 $8.00 762,700 No 4 P Indirect Through Deerfield Special Situations Fund International Limited
Common Stock Acquisiton 2011-05-26 229,252 $8.00 2,279,997 No 4 P Indirect Through Deerfield Partners, L.P.
Common Stock Acquisiton 2011-05-26 301,424 $8.00 3,204,167 No 4 P Indirect Through Deerfield International Limited
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect Through Deerfield Special Situations Fund, L.P.
No 4 P Indirect Through Deerfield Special Situations Fund International Limited
No 4 P Indirect Through Deerfield Partners, L.P.
No 4 P Indirect Through Deerfield International Limited
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 25,000 Direct
Footnotes
  1. This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the "Reporting Persons").
  2. Deerfield Capital, L.P. is the general partner of Deerfield Special Situations Fund, L.P. and Deerfield Partners, L.P. (the "Onshore Funds"). James E. Flynn is the managing member of the general partner of Deerfield Capital, L.P. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Onshore Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.
  3. Deerfield Management Company, L.P. is the investment manager of Deerfield Special Situations Fund International Limited and Deerfield International Limited (the "Offshore Funds"). James E. Flynn is the managing member of the general partner of Deerfield Management Company, L.P. In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Offshore Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.